Statins and Angiotensin‐Converting Enzyme Inhibitors are Associated with Reduced Mortality and Morbidity in Chronic Liver Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|122|1|104-110

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.122, Iss.1, 2018-01, pp. : 104-110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin‐converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 4, 2015-04 ,pp. : 593-596

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors and Smoking Cessation

By  

Respiration, Vol. 74, Iss. 4, 2007-05 ,pp. : 478-478

Karger

Access to resources Recommend Favorite

Evaluating the Use of Angiotensin‐Converting Enzyme Inhibitors For Older Nursing Home Residents with Chronic Heart Failure

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 12, 1998-12 ,pp. : 1550-1554

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

By  

Nephron Clin Pract, Vol. 121, Iss. 1-2, 2012-10 ,pp. : c73-c82

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors as a Risk Factor for Contrast-Induced Nephropathy

By  

Nephron Clin Pract, Vol. 104, Iss. 1, 2006-05 ,pp. : c20-c27

Karger

Access to resources Recommend Favorite